Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Vineet Laboratories Limited

Market Cap 56Cr 58.72L 50.72L 46.73L 43.75L 81.98L 83.25L 5.52Cr 2.15Cr 27Cr 2.2Cr 2.16Cr 94Cr P/E Ratio 2024
43.6x
P/E Ratio 2025 -1.42x
Enterprise Value 96Cr 1.01Cr 86.83L 80.01L 74.89L 1.4Cr 1.43Cr 9.45Cr 3.68Cr 47Cr 3.77Cr 3.69Cr 161.04Cr EV / Sales 2024
5,87,502x
EV / Sales 2025 8,90,202x
Free-Float
62.66%
Yield 2024 *
-
Yield 2025 -
1 day-1.54%
1 week-2.30%
1 month-1.96%
3 months+15.58%
6 months-20.89%
Current year-7.64%
1 week 33.06
Extreme 33.06
34.9
1 month 32.76
Extreme 32.76
37.4
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
124
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Chief Executive Officer 56 10/11/2016
Director of Finance/CFO 76 01/01/2021
Human Resources Officer - -
Director TitleAgeSince
Director/Board Member 56 10/11/2016
Director/Board Member 76 10/11/2016
Chairman 73 16/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.54%-2.30%+13.23%-34.04% 68.64L
-2.41%+0.14%+38.28%+154.20% 1,01000Cr
+1.07%+3.48%+53.32%+49.85% 58TCr
+1.32%+0.22%+19.18%+64.65% 40TCr
+0.77%0.00%+21.28%+16.70% 33TCr
+0.44%+3.48%+25.65%+35.66% 28TCr
-0.85%-2.86%+22.54%+14.67% 28TCr
+1.66%+1.20%-44.35%-47.35% 20TCr
+0.32%+1.61%+20.32%+60.01% 19TCr
-0.22%-2.76%+14.19%+60.09% 16TCr
Average +0.06%+0.53%+18.36%+37.44% 34.29TCr
Weighted average by Cap. -0.23%+1.04%+27.77%+70.54%

Financials

2024 2025
Net sales 1.51T 15.88 13.72 12.64 11.83 22.17 22.52 149.26 58.2 734.8 59.61 58.34 2.54T 769.53 8.1 6.99 6.44 6.03 11.3 11.48 76.08 29.66 374.56 30.38 29.74 1.3T
Net income 1.03Cr 1L 93.33T 86T 80.5T 2L 2L 10.16L 4L 49.99L 4L 4L 1.73Cr -20Cr -21.24L -18.35L -16.91L -15.83L -29.66L -30.12L -2Cr -77.83L -9.83Cr -79.72L -78.03L -34Cr
Net Debt 44Cr 46.37L 40.05L 36.9L 34.54L 64.74L 65.74L 4.36Cr 1.7Cr 21Cr 1.74Cr 1.7Cr 74Cr 40Cr 41.81L 36.11L 33.28L 31.15L 58.37L 59.28L 3.93Cr 1.53Cr 19Cr 1.57Cr 1.54Cr 67Cr
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
12/26/12 33.97 -1.54% 35,451
11/26/11 34.50 +3.76% 20,821
10/26/10 33.25 -1.36% 10,060
09/26/09 33.71 +0.96% 13,503
08/26/08 33.39 -3.97% 41,251
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!